Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price
Senores Pharmaceuticals Share Price: Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels, ending 6% below listing price.
